The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases

Medicine and Dentistry

• Phosphotransferase Inhibitor 100%
• Serositis 100%
• Phosphotransferase 100%
• Kinase 100%
• STAT1 Protein 66%
• Immunoblotting 66%
• Transcription Factor AP 1 66%
• Malignant Neoplasm 33%
• Amino Terminal Sequence 33%
• Macrophage 33%
• Colitis 33%
• Cancer Growth Factor 33%
• Immune Response 33%
• Cytotoxicity 33%
• Protein Kinase B 33%
• Nuclear Factor 33%
• Adenosine Triphosphate 33%
• Antiinflammatory Activity 33%
• Lipopolysaccharide 33%
• Janus Kinase 2 33%
• Luciferase 33%
• Anti-Inflammatory Drug 33%
• Alternative Complement Pathway C3 C5 Convertase 33%
• Luciferase Assay 33%
• Inflammatory Mediator 33%
• Immunoprecipitation 33%
• Kinase Assay 33%
• Phosphoinositide Dependent Protein Kinase 1 33%
• Gram-Positive Bacteria 33%
• Reporter Gene 33%
• Interferon Regulatory Factor 3 33%
• Competitive Inhibition 33%
• Mitogen Activated Protein Kinase Kinase Kinase 4 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammation 100%
• Phosphotransferase 100%
• Phosphotransferase Inhibitor 100%
• Western Blot 50%
• Transcription Factor AP 1 50%
• Luciferase 50%
• STAT1 Protein 50%
• Malignant Neoplasm 25%
• Anti-Inflammatory Drug 25%
• Alternative Complement Pathway C3 C5 Convertase 25%
• Nuclear Factor 25%
• Antiinflammatory Activity 25%
• Cancer Growth Factor 25%
• Cytotoxicity 25%
• Lipopolysaccharide 25%
• Protein Kinase B 25%
• Interferon Regulatory Factor 3 25%
• Colitis 25%
• Competitive Inhibitor 25%
• Gram Positive Bacterium 25%
• Adenosine Triphosphate 25%
• Immunoprecipitation 25%
• Janus Kinase 2 25%
• Phosphoinositide Dependent Protein Kinase 1 25%
• Mitogen Activated Protein Kinase Kinase Kinase 4 25%